Retatrutide 30mg
30mg
Retatrutide 30mg offers an extended research supply of the groundbreaking triple agonist (GLP-1, GIP, glucagon) compound that is reshaping metabolic science. Retatrutide has shown greater efficacy in weight loss research than any previous generation of incretin-based peptides, with studies reporting double-digit percentage reductions in body mass. This larger 30mg vial is ideal for longer-duration protocols or comparative dose-response studies. Third-party HPLC tested. Lyophilised powder, requires reconstitution with bacteriostatic water.
Crypto payments only — How to pay guide
Documentation
COA-backed
Source
Manufacturer COA
Shipping
Australia-wide
Payment
Crypto only
RetaLABS Retatrutide 30mg is the larger-format lyophilised research vial of LY3437943, suited to extended protocols. At the 4mg/week Phase 2 starting dose, a single 30mg vial supplies 7.5 weeks of research. Researchers running higher-dose cohorts benefit from fewer reconstitution events and reduced vial waste per protocol compared to the 20mg format.
Supplied as a white lyophilised powder. Shipped via Express Post Australia-wide in discrete, unmarked packaging — typically dispatched within 1–2 business days of confirmed crypto payment (BTC, LTC, or XMR).
For reconstitution protocol and storage guidance see the Peptide Reconstitution Guide. For Phase 2 trial data and dosing schedules see the Retatrutide Dosing Protocol.
Product Specifications
COA-backed, manufacturer-verified
Lyophilised powder
~4.4 kDa
-20°C (lyophilised), 2-8°C (reconstituted)
Bacteriostatic water or sterile saline
Available upon request
Research Use Only: These products are intended for laboratory research use only and are not approved for human consumption. All purchases are subject to our terms of service and local regulations.
Frequently Asked Questions
Everything you need to know about Retatrutide 30mg
Research Guides
Retatrutide Australia 2026: Research Guide, Mechanism, Trial Data & Reconstitution
15 min read
Retatrutide 2026: Phase 3 Trials and What Researchers Should Know
6 min read
Retatrutide vs Tirzepatide: Triple vs Dual GLP-1 Agonism in Research
8 min read
Buying Research Peptides with Crypto in Australia: A Practical Guide
5 min read
Retatrutide Dosing Protocol: Phase 2 Trial Reference for Researchers
8 min read